210
Participants
Start Date
March 13, 2023
Primary Completion Date
April 30, 2028
Study Completion Date
May 31, 2028
ASP1002
intravenous (IV) infusion
RECRUITING
Icahn School of Medicine at Mount Sinai, New York
RECRUITING
Swedish Cancer Institute, Edmonds
RECRUITING
NEXT Oncology Virginia, Fairfax
WITHDRAWN
Prisma Health-Upstate Cancer Institute, Greenville
RECRUITING
University of Florida, Gainesville
COMPLETED
SCRI Oncology Partners, Nashville
RECRUITING
Norton Cancer Institute, Louisville
RECRUITING
University Hospitals of Cleveland, Cleveland
RECRUITING
Henry Ford Hospital, Detroit
RECRUITING
University of Iowa Hospitals, Iowa City
RECRUITING
HealthPartners Cancer Research Center, Saint Paul
COMPLETED
University of Texas Southwestern, Dallas
RECRUITING
Mary Crowley Cancer Research Center, Dallas
RECRUITING
Yale University Cancer Center, New Haven
RECRUITING
Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut, Plainville
Astellas Pharma Global Development, Inc.
INDUSTRY